SCHEMBL1795271

SCHEMBL1795271

Cc1sc(NC(=O)COCC(=O)N2CCN(C(c3ccccc3)c3ccccc3)CC2)c(C(=O)OC(C)(C)C)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.50
NPC1 O15118 1/20 0.49
GAA P10253 1/20 0.48
ALDH1A1 P00352 5/20 0.44
LMNA P02545 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
CACNA2D1 P54289 4/20 0.40
CACNB1 Q02641 4/20 0.40
CACNA1B Q00975 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PTBP1 P26599 1/20 0.40
LDHA P00338 1/20 0.40
THRB P10828 1/20 0.40
HTT P42858 1/20 0.40
CACNA1A O00555 1/20 0.40
CACNA1C Q13936 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1802271 0.95 SERPINE1 (0.47) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1796499 0.93 SERPINE1 (0.45) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1797144 0.90 SERPINE1 (0.56) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL17530216 0.89 SERPINE1 (0.56) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1798992 0.88 SERPINE1 (0.52) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1794795 0.85 SERPINE1 (0.53) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1795054 0.84 ALDH1A1 (0.53) GAAALDH1A1LMNAMEN1KMT2A
SCHEMBL1798841 0.83 ALDH1A1 (0.52) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1796315 0.83 SERPINE1 (0.51) SERPINE1NPC1GAAALDH1A1LMNA
SCHEMBL1799596 0.82 ALDH1A1 (0.45) GAAALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885NPC1 1319/4885GAA 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.